ial and truncal acne in Indian subjects. Abstract #75617. Poster presented at 2026 AAD Annual Meeting; March 27-31, 2026; United States.

Dreno B, et al. Real-world evidence for a holistic regimen with trifarotene in acne and acne sequelae: Improving acne treatment outcomes and skin quality through personalized regimens. Abstract #73768. Poster presented at 2026 AAD Annual Meeting; March 27-31, 2026; United States.

Gold LS, et al. From tretinoin to trifarotene: Fifty years of innovation in acne and skin health. Abstract #73796. Poster presented at 2026 AAD Annual Meeting; March 27-31, 2026; United States.

Li MK, et al. The fourth-generation retinoid: Rational molecular design of trifarotene, selectivity, efficacy, and clinical outcomes. Abstract #73785. Poster presented at 2026 AAD Annual Meeting; March 27-31, 2026; United States.

Farah M, et al. Identifying high-risk factors for sensitive skin through artificial intelligence: A cross-sectional analysis. Abstract
=*=*=*=*=*=
当前为第13/17页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页